top of page

Is Alzheimer's the most expensive disease in the country? ~ Domenico Pratico', MD, FCPP

Writer: Dr Domenico PraticoDr Domenico Pratico

Updated: Nov 26, 2024


Is Alzheimer's the most expensive disease in the country? - Dr Domenico Pratico

Alzheimer's disease continues to be a profoundly significant public health concern in the United States and other developed nations. In fact, it is estimated that taxpayers bear a staggering cost of approximately $20 million per hour to address this disease. Within the USA, the total national expenditure for providing care to individuals with Alzheimer's and other dementias exceeds a staggering $300 billion annually.


With the increasing number of Americans affected by Alzheimer's, it is projected that the combined annual expenditure for healthcare, long-term care, and hospice services for individuals with Alzheimer's and other dementias will skyrocket to surpass $1 trillion by 2050.


These statistics emphasize the immense financial burden associated with Alzheimer's disease, making it one of the most expensive diseases in the country. The costs encompass various aspects, including medical care, support services, long-term care facilities, and end-of-life care.


The economic impact of Alzheimer's extends beyond the direct expenses incurred by individuals and families. It affects government resources, healthcare systems, and taxpayers at large. Addressing this disease's financial implications necessitates a comprehensive approach that encompasses research funding, support programs, caregiver resources, and improved access to quality care.


By understanding the enormity of the financial strain caused by Alzheimer's disease, policymakers, researchers, and society at large can strive towards implementing effective strategies to mitigate the economic burden, enhance support systems, and ultimately work towards finding a cure for this devastating disease.


If you like this blog post, I also wrote about - Is Early Detection of AD Important? - Dr Domenico Pratico Domenico Praticò, MD, is the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research, Professor and Founding Director of the Alzheimer’s Center at Temple, and Professor of Pharmacology at the Lewis Katz School of Medicine at Temple University You can find out more information on Dr. Domenico Pratico's research papers here. Connect with Dr. Domenico Pratico on LinkedIn, Facebook, Twitter & Instagram Follow Dr Domenico Pratico's lab website here: Pratico Lab

 
 
 

Comments


Pratico Lab

Pratico Lab's research area is clinical pharmacology with a special focus on the cellular and molecular aspects of cell oxidative biology and a particular interest in small molecules such as bioactive oxidized lipids.

3500 North Broad Street
MERB 660, Philadelphia, PA 19140, USA

Follow Us

  • LinkedIn
  • X
  • Instagram
  • Facebook

Thanks for submitting!

© 2023 by Pratico Lab. All Rights Reserved.

bottom of page